| A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis (NCT04680676) | Boehringer Ingelheim | 2022-05-02 |
| Novel Complex Radiodiagnostics of Peripherial Arthropathies (NCT05657847) | Semmelweis University | 2022-03-07 |
| A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis (NCT05083078) | Janssen Research & Development, LLC | 2021-11-04 |
| A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis (NCT05071664) | Janssen Research & Development, LLC | 2021-10-25 |
| A Long-term Extension Study of Ustekinumab in Pediatric Participants (NCT05092269) | Janssen Research & Development, LLC | 2021-10-18 |
| Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent (NCT04936308) | Janssen Research & Development, LLC | 2021-09-28 |
| A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease (NCT04929210) | Janssen Research & Development, LLC | 2021-08-30 |
| A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice (NCT05049798) | Janssen Pharmaceutica N.V., Belgium | 2021-08-25 |
| A Study of Guselkumab in Participants With Active Psoriatic Arthritis (NCT04882098) | Janssen Research & Development, LLC | 2021-06-17 |
| PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors (NCT04821206) | Liga Panamericana de Asociaciones de Reumatologia (PANLAR) | 2021-03-01 |
| Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response. (NCT04731831) | Aalborg University Hospital | 2020-08-01 |
| Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis (NCT04115020) | Brigham and Women's Hospital | 2020-01-01 |
| A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis (NCT05000086) | Peking Union Medical College Hospital | 2019-06-01 |
| WORKWELL: Testing Work Advice for People With Arthritis (NCT03942783) | University of Salford | 2019-03-22 |
| A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy (NCT03796858) | Janssen Pharmaceutica N.V., Belgium | 2019-03-22 |
| A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment (NCT03828045) | Amgen | 2019-02-06 |
| A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis (NCT03733925) | Johnson & Johnson Private Limited | 2019-01-07 |
| Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. (NCT03747939) | Amgen | 2018-12-31 |
| Central Pain Mechanisms in Patients With Hand-Osteoarthritis, Psoriatic Arthritis and Healthy Controls (NCT03703934) | Aalborg University Hospital | 2018-10-20 |
| Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis (NCT03625089) | Chinese University of Hong Kong | 2018-09-01 |
| Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis (NCT04173039) | Association pour la Recherche Clinique et Immunologique | 2018-08-29 |
| Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE) (NCT03608657) | Amgen | 2018-07-31 |
| Fertility Study of Women With Chronic Inflammatory Rheumatism (NCT03452735) | University Hospital, Toulouse | 2018-07-16 |
| One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (NCT03662919) | Biogen | 2018-07-02 |
| Low Dose Naltrexone for Chronic Pain From Arthritis (NCT03008590) | VA Office of Research and Development | 2018-05-01 |
| A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) (NCT03162796) | Janssen Research & Development, LLC | 2017-08-24 |
| A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis (NCT03158285) | Janssen Research & Development, LLC | 2017-07-12 |
| Stepping Up For Inflammatory Arthritis (NCT02912221) | University of Pennsylvania | 2017-04-24 |
| A Study of the Real-life Management of Psoriatic Arthritis Patients Treated With Otezla® (Apremilast) in Belgium (NCT03096990) | Amgen | 2017-04-21 |
| Ultrasound in Psoriatic Arthritis Treatment (NCT03330769) | University of Cagliari | 2017-02-03 |
| BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis (NCT02719171) | AbbVie | 2016-04-01 |
| Study of Apremilast Use in Patients With Psoriatic Arthritic in Practice Conditions (NCT03106051) | Amgen | 2016-02-18 |
| Mechanism of Action of Ustekinumab in Psoriatic Arthritis (NCT03565042) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2015-12-08 |
| Psoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease Activity (NCT06676176) | Barts & The London NHS Trust | 2015-06-01 |
| MYL-1401A Efficacy and Safety Comparability Study to Humira® (NCT02714322) | Mylan Inc. | 2015-06-01 |
| 16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Psoriatic Arthritis (NCT02294227) | Novartis Pharmaceuticals | 2015-05-29 |
| Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening? (NCT02436785) | University of British Columbia | 2015-05-06 |
| Follow-up of Person-centered Care of Young Adults With Rheumatic Disease (NCT02402894) | Vastra Gotaland Region | 2015-02-01 |
| A Study of Golimumab in Participants With Active Psoriatic Arthritis (NCT02181673) | Janssen Research & Development, LLC | 2014-09-08 |
| Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis (NCT02098694) | Norwegian University of Science and Technology | 2014-06-01 |
| Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (NCT01976364) | Pfizer | 2014-02-17 |
| The DIET Trial - Dietetic Intervention in Psoriatic Arthritis (NCT03142503) | Federal University of São Paulo | 2013-01-21 |
| Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy (NCT01490450) | CSL Behring | 2011-12-01 |
| A Study of RO5310074 in Patients With Psoriatic Arthritis (NCT01199809) | Hoffmann-La Roche | 2011-02-01 |
| Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis (NCT00998829) | Pfizer | 2010-05-01 |
| A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents (NCT01077362) | Janssen Research & Development, LLC | 2010-03-01 |
| Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis (NCT01087788) | UCB BIOSCIENCES GmbH | 2010-03-01 |
| A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis (NCT01009086) | Janssen Research & Development, LLC | 2009-12-01 |
| Golimumab Safety and Surveillance Program Using the Ingenix NHI Database (NCT01081717) | Janssen Biotech, Inc. | 2009-04-14 |
| Single Dose PG102 in Patients With Active Psoriatic Arthritis (NCT00787137) | PanGenetics UK Limited | 2008-12-01 |
| An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants (NCT00760669) | Janssen Korea, Ltd., Korea | 2007-05-01 |
| Study Evaluating the Safety of Enbrel (Etanercept) (NCT00683384) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France (NCT02886689) | Central Hospital, Nancy, France | 2007-01-01 |
| Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422) (NCT00367237) | Merck Sharp & Dohme LLC | 2006-05-01 |
| PsA Treatment With hOKT3γ1 (Ala-Ala) (NCT00239720) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-03-16 |
| Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis (NCT00273858) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840) (NCT00727298) | Merck Sharp & Dohme LLC | 2006-02-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists (NCT00293722) | Pfizer | 2006-01-01 |
| Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists (NCT00293709) | Pfizer | 2006-01-01 |
| A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic Arthritis (NCT00265096) | Centocor, Inc. | 2005-12-01 |
| Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects (NCT00126724) | Targeted Genetics Corporation | 2005-08-01 |
| Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis (NCT00161655) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-04-01 |
| Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264) (NCT00725296) | Merck Sharp & Dohme LLC | 2004-12-01 |
| Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis (NCT00938015) | Pfizer | 2004-10-01 |
| Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis (NCT00090129) | EMD Serono | 2004-09-01 |
| A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis (NCT00051623) | Centocor, Inc. | 2003-05-01 |
| Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain (NCT00195377) | Wyeth is now a wholly owned subsidiary of Pfizer | 2003-04-01 |
| Biologic Treatment Registry Across Canada (NCT00741793) | Janssen Inc. | 2002-02-12 |
| A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis (NCT00001422) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1995-06-01 |
| Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions (NCT00001291) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1991-12-01 |